A phase I trial of Herceptin [trastuzumab] and interleukin-12
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2013
At a glance
- Drugs Interleukin-12 (Primary) ; Trastuzumab (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 25 Apr 2011 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 05 Mar 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov.